Good morning, everybody. We're waiting for the few final people to pop into the conference, and we'll get started in just a few seconds. Everybody has joined the conference. So Randy, good to go.

Gross margins improved dramatically from 21% to 41% year-over-year. Operating expenses were reduced by 35% compared to the previous year. Revenue grew by 4.2% quarter-over-quarter, reaching CAD ...

Earnings call Legend Power Systems reported Q2 FY2025 revenue of $523,000, up 322% YoY, with gross margin dollars doubling despite margin percentage declining to 22% due to product mix and component ...

Good day, and welcome to the Legend Biotech Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a ...

MS. TUMULTY: Hello, and welcome to Washington Post Live. I’m Karen Tumulty, a columnist and associate editor here at The Post, and it’s my great honor today to welcome my colleague, Max Boot, to talk ...

Legend Biotech (LEGN) is scheduled to announce Q3 earnings results on Tuesday, November 11th, before market open. The consensus EPS Estimate is -$0.12 (+64.7% Y/Y) and the consensus Revenue Estimate ...

Earnings call Legend Power Systems delivered flat revenue of CAD 545,000 in Q2 2026, with gross margin doubling YoY to 41% due to cost reductions. Management highlighted a significant order intake in ...

Revenue: CAD 545,000, up 4.2% from CAD 523,000 in Q1 2026. Gross Margin: 41%, a significant increase from 21% year-over-year. Operating Expenses: CAD 658,000, down 35% from Q2 2025. Inventory ...